Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow NEOG
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| May '26 | May '25 | May '24 | May '23 | May '22 | May '21 | May '20 | May '19 | May '18 | May '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
185.50 | 129.00 | 170.94 | 245.57 | 381.05 | 381.09 | 343.67 | 267.52 | 210.81 | 143.64 |
Receivables |
146.80 | 153.40 | 173.01 | 153.25 | 99.67 | 91.82 | 84.68 | 82.58 | 79.09 | 68.58 |
Inventory |
144.30 | 190.80 | 189.27 | 133.81 | 122.31 | 100.70 | 95.05 | 85.99 | 76.01 | 73.14 |
Other current assets |
68.00 | 50.40 | — | 53.00 | 24.00 | 18.00 | 14.00 | 13.00 | 9.89 | 7.61 |
Total current assets |
604.60 | 576.90 | 589.23 | 585.93 | 626.80 | 591.45 | 537.41 | 449.53 | 375.79 | 292.96 |
Property, Plant, Equpment (Net) |
329.80 | 339.10 | 277.10 | 198.75 | 110.58 | 100.45 | 78.67 | 74.85 | 73.07 | 61.75 |
Goodwill and Intangible Assets (Total) |
2,365.20 | 2,475.40 | 3,647.29 | 3,742.60 | 250.21 | 223.79 | 176.92 | 171.23 | 169.15 | 155.07 |
Long-term assets (Other) |
29.80 | 35.20 | 20.43 | 15.22 | 2.16 | 2.02 | 2.23 | 0.14 | — | 18.64 |
Total non-current assets |
2,741.40 | 2,866.90 | 3,959.60 | 3,968.50 | 366.13 | 328.74 | 259.78 | 246.21 | 242.22 | 235.45 |
Total Assets |
3,346.00 | 3,443.80 | 4,548.83 | 4,554.43 | 992.93 | 920.19 | 797.18 | 695.74 | 618.01 | 528.41 |
Accounts Payable |
79.10 | 79.60 | 83.06 | 76.67 | 34.61 | 23.90 | 25.65 | 19.06 | 20.75 | 16.24 |
Accrued Expenses |
37.80 | 25.20 | 35.57 | 36.30 | 41.10 | 27.85 | 21.38 | 18.59 | 17.94 | 19.76 |
Current Part of Debt |
— | 19.30 | 2.45 | 3.00 | 1.00 | 1.00 | 1.00 | — | — | — |
Current Part of Taxes to Pay |
7.20 | 5.60 | 10.45 | 6.95 | 2.13 | 1.85 | 1.46 | 0.60 | — | — |
Current Revenue (Deferred) |
3.60 | 5.60 | 4.63 | 4.62 | — | — | — | — | — | — |
Other current liabilities |
30.50 | 38.70 | 22.80 | 20.93 | 40.00 | 27.00 | 20.00 | 19.00 | 17.77 | 18.82 |
Total current liabilities |
158.20 | 174.00 | 154.32 | 145.47 | 77.84 | 53.60 | 48.49 | 38.25 | 38.69 | 36.00 |
Long Term Debt (Total) |
793.70 | 874.80 | 888.39 | 885.44 | 0.00 | 0.00 | 0.00 | — | — | — |
Long Term Tax Liability (Deferred) |
257.60 | 280.90 | 326.72 | 353.43 | 17.01 | 21.92 | 18.13 | 15.62 | 14.10 | 17.05 |
Non-current Liabilities (Other) |
43.60 | 42.90 | 35.26 | 35.88 | 10.70 | 4.30 | 5.39 | 3.97 | 5.04 | 3.60 |
Total non-current liabilities |
1,094.90 | 1,198.60 | 1,250.37 | 1,274.74 | 27.71 | 26.22 | 23.52 | 19.59 | 19.15 | 20.65 |
Total liabilities |
1,253.10 | 1,372.60 | 1,404.69 | 1,420.22 | 105.56 | 79.82 | 72.01 | 57.84 | 57.83 | 56.65 |
Additional Paid In Capital |
2,616.00 | 2,601.80 | 2,583.89 | 2,567.83 | 309.98 | 294.95 | 249.22 | 221.94 | 202.57 | 174.74 |
Common Stock (Net) |
34.80 | 34.70 | 34.66 | 34.60 | 17.25 | 17.20 | 16.94 | 8.36 | 8.28 | 8.15 |
Retained Earnings |
(544.30) | (536.40) | 555.62 | 565.04 | 587.91 | 539.60 | 478.72 | 419.25 | 359.07 | 295.93 |
Common Equity (Total) |
2,092.90 | 2,071.20 | 3,144.14 | 3,134.22 | 887.37 | 840.38 | 725.18 | 637.90 | 560.18 | 471.76 |
Shareholders Equity (Total) |
2,092.90 | 2,071.20 | 3,144.14 | 3,134.22 | 887.37 | 840.38 | 725.18 | 637.90 | 560.18 | 471.76 |
Shareholders Equity and Liabilities (Total) |
3,346.00 | 3,443.80 | 4,548.83 | 4,554.43 | 992.93 | 920.19 | 797.18 | 695.74 | 618.01 | 528.41 |
Shares (Common) |
217.70 | 217.00 | 216.61 | 216.25 | 107.80 | 107.47 | 105.89 | 104.43 | 103.47 | 101.86 |
Shareholders Equity (Tangible) |
(272.30) | (404.20) | (503.14) | (608.38) | 637.17 | 616.59 | 548.26 | 466.67 | 391.02 | 316.69 |
Net Debt |
608.20 | 765.10 | 719.90 | 642.87 | (380.05) | (380.09) | (342.67) | (267.52) | (210.81) | (143.63) |
Total Debt |
793.70 | 894.10 | 890.84 | 888.44 | 1.00 | 1.00 | 1.00 | — | — | — |